Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

NCT06066424 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Rimiducid
DRUG: TROP2-CAR-NK Cells
DRUG: Fludarabine phosphate
DRUG: Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]